BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18539344)

  • 21. Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex Virus.
    Sato Y; Suenaga T; Kobayashi M; Miyazaki N; Suzuki T; Ishioka K; Suzutani T
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0049421. PubMed ID: 34228537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.
    Biswas S; Sukla S; Field HJ
    Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients.
    Labrunie T; Ducastelle S; Domenech C; Ader F; Morfin F; Frobert E
    Antiviral Res; 2019 Aug; 168():114-120. PubMed ID: 31152759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
    Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicase primase: targeting the Achilles heel of herpes simplex viruses.
    Kleymann G
    Antivir Chem Chemother; 2004 May; 15(3):135-40. PubMed ID: 15266895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.
    Biswas S; Sukla S; Goldner T; Field HJ; Kropeit D; Paulsen D; Welbers A; Ruebsamen-Schaeff H; Zimmermann H; Birkmann A
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3843-52. PubMed ID: 24752278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutation in the human herpes simplex virus type 1 UL52 zinc finger motif results in defective primase activity but can recruit viral polymerase and support viral replication efficiently.
    Chen Y; Livingston CM; Carrington-Lawrence SD; Bai P; Weller SK
    J Virol; 2007 Aug; 81(16):8742-51. PubMed ID: 17553899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The three-component helicase/primase complex of herpes simplex virus-1.
    Bermek O; Williams RS
    Open Biol; 2021 Jun; 11(6):210011. PubMed ID: 34102080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
    Lebel A; Boivin G
    J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of the Phosphorylation of Herpes Simplex Virus 1 UL51 at a Specific Site in Viral Replication and Pathogenicity.
    Kato A; Oda S; Watanabe M; Oyama M; Kozuka-Hata H; Koyanagi N; Maruzuru Y; Arii J; Kawaguchi Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline sensitivity of HSV-1 and HSV-2 clinical isolates and defined acyclovir-resistant strains to the helicase-primase inhibitor pritelivir.
    Field HJ; Huang ML; Lay EM; Mickleburgh I; Zimmermann H; Birkmann A
    Antiviral Res; 2013 Nov; 100(2):297-9. PubMed ID: 24021190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antiviral drugs that target herpesvirus helicase primase enzymes.
    Kleymann G
    Herpes; 2003 Aug; 10(2):46-52. PubMed ID: 14577954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.
    Betz UA; Fischer R; Kleymann G; Hendrix M; Rübsamen-Waigmann H
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1766-72. PubMed ID: 12019088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection.
    Katsumata K; Chono K; Suzuki H
    Biochem Pharmacol; 2018 Dec; 158():201-206. PubMed ID: 30365949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
    Pertel PE; Spear PG
    Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
    Katsumata K; Chono K; Kato K; Ohtsu Y; Takakura S; Kontani T; Suzuki H
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1339-46. PubMed ID: 23274658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.
    Barnard EC; Brown G; Stow ND
    Virology; 1997 Oct; 237(1):97-106. PubMed ID: 9344911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes simplex virus 1 primase employs watson-crick hydrogen bonding to identify cognate nucleoside triphosphates.
    Ramirez-Aguilar KA; Moore CL; Kuchta RD
    Biochemistry; 2005 Nov; 44(47):15585-93. PubMed ID: 16300408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.